Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, NIH Pathway to Independence Award (K99/R00).                    

*Date:*                         March 2, 2016.                    

*Time:*                         9:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, 301-435-1426,                         *mcguireso@mail.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01).                    

*Date:*                         March 2, 2016.                    

*Time:*                         12:00 p.m. to 1:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Jose F. Ruiz, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, (301) 451-3086,                         *ruizjf@nida.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3).                    

*Date:*                         March 4, 2016.                    

*Time:*                         8:30 a.m. to 12:30 p.m.                    

*Agenda:*                         To review and evaluate cooperative agreement applications.                     

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.                    

*Contact Person:*                         Jose F. Ruiz, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, (301) 451-3086,                         *ruizjf@nida.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Phase II in person interview: Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2).                     

*Date:*                         March 8, 2016.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815.                    

*Contact Person:*                         Hiromi Ono, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301-402-6020,                         *hiromi.ono@nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Phase II in person interview: Avenir Award Program for Genetics or Epigenetics of Substance Abuse (DP1).                    

*Date:*                         March 10, 2016.                     

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815.                         *Contact Person:*                         Hiromi Ono, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301-402-6020,                         *hiromi.ono@nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33).                    

*Date:*                         March 11, 2016.                    

*Time:*                         1:00 p.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Jose F. Ruiz, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, (301) 451-3086,                         *ruizjf@nida.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Loan Repayment 2016.                    

*Date:*                         March 15, 2016.                    

*Time:*                         9:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications and/or proposals.                    

*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).                    

*Contact Person:*                         Lyle Furr, Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-9550, (301) 435-1439,                         *lf33c.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, NIDA Research “Center of Excellence” Grant Program (P50).                    

*Date:*                         March 16, 2016.                    

*Time:*                         9:00 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.                    

*Contact Person:*                         Jagadeesh S. Rao, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 301-443-9511,                         *jrao@nida.nih.gov.*

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, NIDA Core Center of Excellence Grant Program (P30).                    

*Date:*                         March 17, 2016.                    

*Time:*                         9:00 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852.                    

*Contact Person:*                         Jagadeesh S. Rao, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National                               ( print page 7552)                            Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 301-443-9511,                         *jrao@nida.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: February 8, 2016.

Natasha M. Copeland,

Program Analyst, Office of Federal Advisory Committee Policy.

 [FR Doc. 2016-02849 Filed 2-11-16; 8:45 am]

 BILLING CODE 4140-01-P